PFE Pfizer Inc.
PFE Pfizer Inc.
Healthcare · Drug Manufacturers - General
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $25.18 · VWAP $26.08 · +15.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster
Coverage
1 related campaign
PFE Price Structure
Loading timeframes…
Peers
Every watchlist PFE belongs to, members best 30-day change first — PFE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare-scan
@healthcare
Pfizer's second-quarter results beat earnings expectations, helped by strong demand for its blood-thinner portfolio, per Reuters (Aug 4 news pull). The company also outlined an additional $2.5 billion in cost cuts to support margins amid ongoing post-pandemic revenue pressure.
full note →Against street estimates
How PFE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
PFE research tape
41 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.